Elena Nikulina

BloFin introduces DNA-USDT perpetual contract for NeoSoulAI featuring maker and taker fee discounts

BloFin introduces DNA-USDT perpetual contract for NeoSoulAI featuring maker and taker fee discounts
BloFin unveils DNA-USDT contract launch

BloFin announced the listing of the DNA-USDT perpetual contract for NeoSoulAI on its futures platform, offering 0% maker fees and a 50% reduction on taker fees.

Leading Forex Broker in United States
6.88/10
*Rated by real traders on Traders Union
  • Chosen by 0+ local traders in the last 3 months.
  • Traders earn on average 12% more per month vs other brokers.
Start with Trading.com USA

BloFin has announced the addition of the DNA-USDT perpetual contract for NeoSoulAI on its futures trading platform. According to the post, the listing features a 0% maker fee and a 50% reduction in taker fees for this contract. No additional information regarding the terms or duration of these fee adjustments was provided in the announcement.

How to participate

To benefit from BloFin's 0% maker fees and 50% off taker fees on the new DNA-USDT perpetual contract, users need to register an account with BloFin. After signing up, log in to your account, and navigate to the futures trading section to trade the DNA-USDT perpetual contract. You can register via the official sign-up link.

BloFin is a centralized cryptocurrency exchange that provides access to spot trading, copy trading, derivatives—including over 300 USDT-M perpetual futures contracts—and automated trading via API. The platform is available on web and mobile, and features security integrations with Fireblocks, along with passive income options for uninvested assets. For further information, see the broker profile on Traders Union.

For more insights into BloFin's recent activities, see the previous BloFin update on Traders Union, which covered BloFin’s role as Title Sponsor at TOKEN2049 Singapore and its latest platform innovations and industry engagement.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.